+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bioxyne Ltd (BXN) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 34 Pages
  • October 2023
  • GlobalData
  • ID: 4412865
Bioxyne Ltd (BXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Bioxyne Ltd (Bioxyne) is a biotechnology company that develops, manufactures, markets, and commercializes healthcare products in the areas of immune health and immunotherapeutic. It manufactures consumer food supplements such as, ProTract and Progastrim, which are based on a proprietary probiotic strain PCC (lactobacillus fermentum). It also develops a range of existing functional food and beauty products containing ingredients sourced from New Zealand. The company caters to consumer dietary supplements and functional foods markets. Its products are used as a foodstuffs, dietary supplements, and beverages. The company has manufacturing and distribution agreements with Chr. Hansen and Nu-Skin Enterprises. Bioxyne is headquartered in Sydney, New South Wales, Australia

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Bioxyne Ltd - Key Facts
  • Bioxyne Ltd - Key Employees
  • Bioxyne Ltd - Key Employee Biographies
  • Bioxyne Ltd - Major Products and Services
  • Bioxyne Ltd - History
  • Bioxyne Ltd - Company Statement
  • Bioxyne Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Bioxyne Ltd - Business Description
  • Business Segment: Direct Sales
  • Performance
  • Business Segment: Plant Based
  • Performance
  • Business Segment: Wholesale Sales
  • Performance
  • Bioxyne Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Bioxyne Ltd - Strengths
  • Bioxyne Ltd - Weaknesses
  • Bioxyne Ltd - Opportunities
  • Bioxyne Ltd - Threats
  • Bioxyne Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Bioxyne Ltd, Recent Deals Summary
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • Contact Us
  • Disclaimer
List of Tables
  • Bioxyne Ltd, Key Facts
  • Bioxyne Ltd, Key Employees
  • Bioxyne Ltd, Key Employee Biographies
  • Bioxyne Ltd, Major Products and Services
  • Bioxyne Ltd, History
  • Bioxyne Ltd, Subsidiaries
  • Bioxyne Ltd, Key Competitors
  • Bioxyne Ltd, Ratios based on current share price
  • Bioxyne Ltd, Annual Ratios
  • Bioxyne Ltd, Interim Ratios
  • Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Bioxyne Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Bioxyne Ltd, Performance Chart (2019 - 2023)
  • Bioxyne Ltd, Ratio Charts
  • Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Amplia Therapeutics Ltd
  • Giaconda Ltd
  • BioCeuticals Pty Ltd
  • Probiotics Australia Pty Ltd
  • BLIS Technologies Ltd
  • Probiotec Ltd